Aquilo Capital Management »

Merus N V shares owned by Aquilo Capital Management

Quarter-by-quarter ownership of Merus N V (MRUS) shares owned by Aquilo Capital Management from 13F filings

Historical chart of Aquilo Capital Management investment in Merus N V

Tip: Access up to 7 years of quarterly data

All positions including Merus N V held by Aquilo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merus N V by Aquilo Capital Management

Quarter filed Position value Share count Share price at filing
2018-09-30 $26M 1.3M 19.74
2018-06-30 $29M 1.3M 22.76

More positions owned by Aquilo Capital Management

SPDR S&P Biotech (XBI)
Merus N V (MRUS)
Loxo Oncology
Fate Therapeutics (FATE)
Aduro Biotech
Synlogic
Cytomx Therapeutics (CTMX)
Pieris Pharmaceuticals (PIRS)
Spero Therapeutics (SPRO)
Xenon Pharmaceuticals (XENE)
Galapagos Nv- (GLPG)
Morphosys (MOR)

View all positions for Aquilo Capital Management

Top funds holding Merus N V

Commodore Capital
Federated Investors
Deerfield Management Company
Samlyn Capital
Wellington Management Company
Boxer Capital
Franklin Resources
VR Adviser
FMR
Lynx1 Capital Management
BlackRock
T. Rowe Price Associates
BVF
Medicxi Ventures Management
Rock Springs Capital Management

View all funds holding Merus N V